ProQR Therapeutics (PRQR) Notes Payables (2017 - 2021)
ProQR Therapeutics (PRQR) posted Notes Payables of $5.5 million for Q4 2021, up 303.32% sequentially from $1.4 million in Q4 2020, and up 303.32% YoY from $1.4 million in Q4 2020.
ProQR Therapeutics (PRQR) Notes Payables (2017 - 2021) Analysis & Trends
ProQR Therapeutics has reported Notes Payables for 5 years, with the latest figure at $5.5 million in Q4 2021.
- Quarterly Notes Payables rose 303.32% year-over-year to $5.5 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $5.5 million (up 303.32% YoY) and the FY2021 annual result came in at $5.6 million, up 335.68% from the prior year.
- Notes Payables rose to $5.5 million in Q4 2021 per PRQR's latest filing, from $1.4 million in the prior quarter.
- Over five years, Notes Payables peaked at $5.5 million in Q4 2021 and troughed at $200007.8 in Q2 2019.
- A 5-year average of $1.5 million and a median of $915531.6 in 2020 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2019 and 2021: Notes Payables tumbled 91.62% in 2019, then soared 303.32% in 2021.
- Over 5 years, Notes Payables stood at $2.3 million in 2017, then increased by 3.43% to $2.4 million in 2018, then sank by 84.09% to $379662.5 in 2019, then jumped by 256.43% to $1.4 million in 2020, then jumped by 303.32% to $5.5 million in 2021.
- According to Business Quant data, Notes Payables over the past three periods registered $5.5 million, $1.4 million, and $1.1 million for Q4 2021, Q4 2020, and Q3 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 5.46 Mn |
| Dec 31, 2020 | 1.35 Mn |
| Sep 30, 2020 | 1.11 Mn |
| Jun 30, 2020 | 722,557.85 |
| Mar 31, 2020 | 572,944.35 |
| Dec 31, 2019 | 379,662.47 |
| Sep 30, 2019 | 289,309.81 |
| Jun 30, 2019 | 200,007.76 |
| Jun 30, 2018 | 2.39 Mn |
| Dec 31, 2017 | 2.31 Mn |